GL
GILD icon

GLG LLC’s Gilead Sciences GILD Stock Holding History

GLG LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$11.5M Hold
160,100
– – 0.82% 21
2017
Q3 		$13M Sell
160,100
-34,400
-18% -$2.63M 0.84% 19
2017
Q2 		$13.8M Buy
194,500
+94,500
+95% +$6.29M 0.85% 21
2017
Q1 		$6.79M Buy
+100,000
New +$7.03M 0.38% 70

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GLG LLC's GILD Position: Q4 2017 in Review

GLG LLC increased its Gilead Sciences (GILD) stake by 40% in Q4 2017, buying an estimated $1.9M and bringing the position to 88,058 shares worth $6.31M. The position accounts for 0.45% of the portfolio, ranked #63.

GLG LLC first reported a position in GILD in Q1 2014 and has held it in 16 quarters since. The position peaked at $24.2M in Q2 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • GLG LLC held 88,058 shares of Gilead Sciences worth $6.31M as of Q4 2017.
  • GLG LLC bought 25,000 Gilead Sciences shares in Q4 2017, an estimated $1.9M.
  • Gilead Sciences made up 0.45% of GLG LLC's portfolio in Q4 2017, its #63 holding.
  • GLG LLC first reported a position in Gilead Sciences in Q1 2014 and has held it in 16 quarters since.
  • GLG LLC's Gilead Sciences position peaked at $24.2M in Q2 2015.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.